Orchestra BioMed
OBIO
OBIO
52 hedge funds and large institutions have $56M invested in Orchestra BioMed in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
82% less call options, than puts
Call options by funds: $27K | Put options by funds: $149K
Holders
52
Holding in Top 10
1
Calls
$27K
Puts
$149K
Top Buyers
| 1 | +$3.39M | |
| 2 | +$2.49M | |
| 3 | +$1.8M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.74M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$902K |
Top Sellers
| 1 | -$182K | |
| 2 | -$133K | |
| 3 | -$122K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$120K |
| 5 |
Millennium Management
New York
|
-$88.5K |
